Physician profile
Kenneth S Jaffe
NPI 1174507529
$3,628.95
in general payments reported to CMS, 2019-2025
35 companies · $233 in 2025
The $233 reported for 2025 was more than what a typical Geriatric Medicine (Internal Medicine) provider received nationally (typical 2025 total: $123).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $344 · 2020: $589 · 2021: $925 · 2022: $878 · 2023: $277 · 2024: $384 · 2025: $233.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $823 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $70.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $823.48 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $70.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $732.60 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Abbvie INC. | $262.74 | 2021-2024 | |
| Otsuka America Pharmaceutical, INC. | $257.13 | 2020-2023 | Jynarque |
| Novo Nordisk INC | $242.99 | 2019-2023 | Wegovy, Rybelsus, Ozempic |
| Astellas Pharma US INC | $205.03 | 2021-2024 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $200.73 | 2021-2025 | |
| Pfizer INC. | $151.14 | 2019-2024 | |
| Allergan, INC. | $140.48 | 2019-2020 | |
| Eisai INC. | $108.08 | 2020-2021 | |
| Glaxosmithkline, LLC. | $103.68 | 2021-2023 | Trelegy Ellipta |
| Abbott Laboratories | $102.25 | 2021-2022 | |
| Exact Sciences Corporation | $97.19 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Orexo US, INC. | $87.26 | 2019-2022 | |
| Biogen, INC. | $83.95 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $77.08 | 2020-2021 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Indivior INC. | $71.58 | 2019-2021 | |
| Currax Pharmaceuticals LLC | $70.31 | 2019-2022 | |
| Becton, Dickinson and Company | $70.00 | 2023-2025 | Bd Introsyte |
| Lilly USA, LLC | $68.47 | 2020-2022 | |
| Novartis Pharmaceuticals Corporation | $58.15 | 2019-2021 | |
| Lundbeck LLC | $52.76 | 2024-2025 | Rexulti |
| Phathom Pharmaceuticals, INC. | $46.34 | 2024-2025 | Voquezna |
| Esperion Therapeutics, INC. | $45.97 | 2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $43.90 | 2025 | Caplyta |
| Kowa Pharmaceuticals America, INC. | $42.78 | 2022 | |
| Merck Sharp & Dohme LLC | $36.73 | 2019-2020 | |
| Biohaven Pharmaceutical Holding Company LTD. | $27.60 | 2022 | |
| Viiv Healthcare Company | $25.21 | 2024 | Apretude |
| Redhill Biopharma INC. | $23.16 | 2020 | |
| Amgen INC. | $20.06 | 2022 | |
| Alkermes, INC. | $19.48 | 2022 | |
| Acera Surgical, INC. | $16.24 | 2022 | |
| Nalpropion Pharmaceuticals LLC | $15.25 | 2019 | |
| Dexcom, INC. | $14.63 | 2023 | Dexcom G6 Transmitter |
| Bardy Diagnostics, INC. | $8.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Jaffe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.